Literature DB >> 20087450

Reduced regional myocardial perfusion reserve is associated with impaired contractile performance in idiopathic dilated cardiomyopathy.

R A Tio1, R H J A Slart, R A de Boer, P A van der Vleuten, R M de Jong, L M van Wijk, T Willems, D D Lubbers, A A Voors, D J van Veldhuisen.   

Abstract

Background. In idiopathic dilated cardiomyopathy (IDC) an imbalance between myocardial oxygen consumption and supply has been postulated. Subclinical myocardial ischaemia may contribute to progressive deterioration of left ventricular function. The relation between regional myocardial perfusion reserve (MPR) and contractile performance was investigated.Methods. Patients with newly diagnosed IDC underwent positron emission tomography (PET) scanning using both (13)N-ammonia as a perfusion tracer (baseline and dypiridamole stress), and (18)F-fluorodeoxyglucose viability tracer and a dobutamine stress MRI. MPR (assessed by PET) as well as wall motion score (WMS, assessed by MRI) were evaluated in a 17-segment model.Results. Twenty-two patients were included (age 49+/-11 years; 15 males, LVEF 33+/-10%). With MRI, a total of 305 segments could be analysed. Wall motion abnormalities at rest were present in 127 (35.5%) segments and in 103 (29.9%) during dobutamine stress. Twenty-one segments deteriorated during stress and 43 improved. MPR was significantly higher in those segments that improved, compared with those that did not change or were impaired during stress (1.87+/-0.04 vs. 1.56+/- 0.07 p<0.01.)Conclusion. Signs of regional ischaemia were clearly present in IDC patients. Ischaemic regions displayed impaired contractility during stress. This suggests that impaired oxygen supply contributes to cardiac dysfunction in IDC. (Neth Heart J 2009;17:470-4.).

Entities:  

Keywords:  cardiac magnetic resonance imaging; endothelial function; idiopathic dilated cardiomyopathy; ischaemia; positron emission tomography

Year:  2009        PMID: 20087450      PMCID: PMC2804079          DOI: 10.1007/BF03086306

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  23 in total

1.  Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy.

Authors:  S Fujioka; Y Kitaura; A Ukimura; H Deguchi; K Kawamura; T Isomura; H Suma; A Shimizu
Journal:  J Am Coll Cardiol       Date:  2000-11-15       Impact factor: 24.094

2.  Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy.

Authors:  A F van den Heuvel; D J van Veldhuisen; E E van der Wall; P K Blanksma; H M Siebelink; W M Vaalburg; W H van Gilst; H J Crijns
Journal:  J Am Coll Cardiol       Date:  2000-01       Impact factor: 24.094

3.  Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging.

Authors:  G D Hutchins; M Schwaiger; K C Rosenspire; J Krivokapich; H Schelbert; D E Kuhl
Journal:  J Am Coll Cardiol       Date:  1990-04       Impact factor: 24.094

4.  Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy.

Authors:  M Kamisago; S D Sharma; S R DePalma; S Solomon; P Sharma; B McDonough; L Smoot; M P Mullen; P K Woolf; E D Wigle; J G Seidman; C E Seidman
Journal:  N Engl J Med       Date:  2000-12-07       Impact factor: 91.245

5.  Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy.

Authors:  S A van den Broek; D J van Veldhuisen; P A de Graeff; M L Landsman; H Hillege; K I Lie
Journal:  Am J Cardiol       Date:  1992-08-01       Impact factor: 2.778

6.  Radionuclide assessment of regional differences in left ventricular wall motion and myocardial perfusion in idiopathic dilated cardiomyopathy.

Authors:  Y Juillière; P Y Marie; N Danchin; C Gillet; F Paille; G Karcher; A Bertrand; F Cherrier
Journal:  Eur Heart J       Date:  1993-09       Impact factor: 29.983

7.  Evaluation of myocardial blood flow reserve in patients with chronic congestive heart failure due to idiopathic dilated cardiomyopathy.

Authors:  Menahem Canetti; Mohammed W Akhter; Amir Lerman; Ilyas S Karaalp; Jason A Zell; Harpreet Singh; Anilkumar Mehra; Uri Elkayam
Journal:  Am J Cardiol       Date:  2003-11-15       Impact factor: 2.778

8.  Quantitative myocardial mapping of perfusion and metabolism using parametric polar map displays in cardiac PET.

Authors:  P K Blanksma; A T Willemsen; J G Meeder; R M de Jong; R L Anthonio; J Pruim; W Vaalburg; K I Lie
Journal:  J Nucl Med       Date:  1995-01       Impact factor: 10.057

9.  Nitric oxide regulates the calcium current in isolated human atrial myocytes.

Authors:  M Kirstein; M Rivet-Bastide; S Hatem; A Bénardeau; J J Mercadier; R Fischmeister
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

10.  Regional coronary flow and contractile reserve in patients with idiopathic dilated cardiomyopathy.

Authors:  Emmanuel I Skalidis; Frangiskos I Parthenakis; Alexandros P Patrianakos; Michael I Hamilos; Panos E Vardas
Journal:  J Am Coll Cardiol       Date:  2004-11-16       Impact factor: 24.094

View more
  11 in total

1.  Cardiomyopathies: a revolution in molecular medicine and cardiac imaging.

Authors:  F J Ten Cate
Journal:  Neth Heart J       Date:  2009-12       Impact factor: 2.380

2.  Diagnostic and therapeutic approach of congenital solitary coronary artery fistulas in adults: Dutch case series and review of literature.

Authors:  S A M Said; R L G Nijhuis; J W Op den Akker; G P Kimman; K G Van Houwelingen; D Gerrits; A B Huisman; R H J A Slart; D M Nicastia; E M Koomen; A C Tans; N Y Y Al-Windy; U Sonker; T Slagboom; A C B Pronk
Journal:  Neth Heart J       Date:  2011-04       Impact factor: 2.380

3.  Myocardial perfusion reserve and contractile pattern after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.

Authors:  R H J A Slart; R A Tio; P A van der Vleuten; T P Willems; D D Lubbers; R A Dierckx; D J van Veldhuisen
Journal:  J Nucl Cardiol       Date:  2010-03-18       Impact factor: 5.952

4.  Coronary endothelial function: a clinical role for PET?

Authors:  Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-12       Impact factor: 9.236

5.  Myocardial perfusion reserve in spared myocardium: correlation with infarct size and left ventricular ejection fraction.

Authors:  Luis Eduardo Juárez-Orozco; Julius Glauche; Erick Alexanderson; Clark J Zeebregts; Hendrikus H Boersma; Andor W J M Glaudemans; Rudi A Dierckx; Dirk J van Veldhuisen; René A Tio; Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-04       Impact factor: 9.236

6.  Gated myocardial SPECT imaging; true additional value in AMI?

Authors:  E E van der Wall; A J Scholte; J J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2010-06-08       Impact factor: 2.357

7.  Myocardial perfusion reserve compared with peripheral perfusion reserve: a [13N]ammonia PET study.

Authors:  A M Scholtens; R A Tio; A Willemsen; R A J O Dierckx; H H Boersma; C J Zeebregts; A W J M Glaudemans; R H J A Slart
Journal:  J Nucl Cardiol       Date:  2011-02-23       Impact factor: 5.952

8.  Assessment of left ventricular function: visual or quantitative?

Authors:  E E van der Wall; J H C Reiber
Journal:  Int J Cardiovasc Imaging       Date:  2010-10-28       Impact factor: 2.357

9.  Assessment of left ventricular volumes; reliable by gated SPECT?

Authors:  E E van derWall; A J H A Scholte; H M Siebelink; J J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2010-10-06       Impact factor: 2.357

10.  PET and MRI for the evaluation of regional myocardial perfusion and wall thickening after myocardial infarction.

Authors:  Riemer H J A Slart; Julius Glauche; Reza Golestani; Clark J Zeebregts; Jan W Jansen; Rudi A J O Dierckx; Matthijs Oudkerk; Tineke P Willems; Andor W J M Glaudemans; Hendrikus H Boersma; René A Tio
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-03-13       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.